Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2019   33,156,000      
Beginning Balance at Dec. 31, 2019 $ 9,756 $ 33 $ 132,214 $ (122,492) $ 1
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   378,000      
Stock-based compensation 1,338   1,338    
Sales of common stock, net of offering costs (in shares)   19,167,000      
Sale of common stock net of offering costs 26,460 $ 19 26,441    
Net loss (8,005)     (8,005)  
Foreign currency translation adjustments, net of tax 9       9
Ending balance (in shares) at Mar. 31, 2020   52,701,000      
Ending Balance at Mar. 31, 2020 29,558 $ 52 159,993 (130,497) 10
Beginning balance (in shares) at Dec. 31, 2019   33,156,000      
Beginning Balance at Dec. 31, 2019 9,756 $ 33 132,214 (122,492) 1
Increase (Decrease) in Stockholders' Equity          
Net loss (21,283)        
Foreign currency translation adjustments, net of tax 44        
Ending balance (in shares) at Sep. 30, 2020   53,396,000      
Ending Balance at Sep. 30, 2020 19,282 $ 53 162,959 (143,775) 45
Beginning balance (in shares) at Mar. 31, 2020   52,701,000      
Beginning Balance at Mar. 31, 2020 29,558 $ 52 159,993 (130,497) 10
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   405,000      
Vesting of restricted stock units 1 $ 1      
Stock-based compensation 1,625   1,625    
Additional offering costs in connection with February sale of common stock (50)   (50)    
Exercise of warrants (in shares)   7,000      
Net loss (7,215)     (7,215)  
Foreign currency translation adjustments, net of tax 8       8
Ending balance (in shares) at Jun. 30, 2020   53,113,000      
Ending Balance at Jun. 30, 2020 23,927 $ 53 161,568 (137,712) 18
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   281,000      
Stock-based compensation 1,388   1,388    
Exercises of stock options (in shares)   2,000      
Exercise of stock options 3   3    
Net loss (6,063)     (6,063)  
Foreign currency translation adjustments, net of tax 27       27
Ending balance (in shares) at Sep. 30, 2020   53,396,000      
Ending Balance at Sep. 30, 2020 $ 19,282 $ 53 162,959 (143,775) 45
Beginning balance (in shares) at Dec. 31, 2020 59,128,356 59,128,000      
Beginning Balance at Dec. 31, 2020 $ 25,053 $ 59 175,813 (150,906) 87
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   195,000      
Stock-based compensation 1,694   1,694    
Sales of common stock, net of offering costs (in shares)   774,000      
Sale of common stock net of offering costs 4,094 $ 1 4,093    
Exercises of stock options (in shares)   104,000      
Exercise of stock options 291   291    
Net loss (8,823)     (8,823)  
Foreign currency translation adjustments, net of tax (62)       (62)
Ending balance (in shares) at Mar. 31, 2021   60,201,000      
Ending Balance at Mar. 31, 2021 $ 22,247 $ 60 181,891 (159,729) 25
Beginning balance (in shares) at Dec. 31, 2020 59,128,356 59,128,000      
Beginning Balance at Dec. 31, 2020 $ 25,053 $ 59 175,813 (150,906) 87
Increase (Decrease) in Stockholders' Equity          
Exercises of stock options (in shares) 105,098        
Net loss $ (26,876)        
Foreign currency translation adjustments, net of tax $ (53)        
Ending balance (in shares) at Sep. 30, 2021 63,182,642 63,183,000      
Ending Balance at Sep. 30, 2021 $ 16,092 $ 63 193,777 (177,782) 34
Beginning balance (in shares) at Mar. 31, 2021   60,201,000      
Beginning Balance at Mar. 31, 2021 22,247 $ 60 181,891 (159,729) 25
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   464,000      
Stock-based compensation 2,230   2,230    
Sales of common stock, net of offering costs (in shares)   2,295,000      
Sale of common stock net of offering costs 7,806 $ 3 7,803    
Net loss (9,069)     (9,069)  
Foreign currency translation adjustments, net of tax 19       19
Ending balance (in shares) at Jun. 30, 2021   62,960,000      
Ending Balance at Jun. 30, 2021 23,233 $ 63 191,924 (168,798) 44
Increase (Decrease) in Stockholders' Equity          
Vesting of restricted stock units (in shares)   222,000      
Stock-based compensation 1,852        
Exercises of stock options (in shares)   1,000      
Exercise of stock options 1   1    
Net loss (8,984)     (8,984)  
Foreign currency translation adjustments, net of tax $ (10)       (10)
Ending balance (in shares) at Sep. 30, 2021 63,182,642 63,183,000      
Ending Balance at Sep. 30, 2021 $ 16,092 $ 63 $ 193,777 $ (177,782) $ 34